- Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
-
Teng ML, Tan DJH, Ng CH, Huang DQ
- KMID: 2541429
- Clin Mol Hepatol.
- 2023 Apr;29(2):404-407.
- doi: 10.3350/cmh.2023.0069
-
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
-
Ng CH, Huang DQ, Nguyen MH
- KMID: 2534343
- Clin Mol Hepatol.
- 2022 Oct;28(4):790-801.
- doi: 10.3350/cmh.2022.0070
Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world’s adult population and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Global incidence and prevalence of nonalcoholic fatty liver disease
-
Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD
- KMID: 2539788
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S32-S42.
- doi: 10.3350/cmh.2022.0365
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males... -
- CITED
-
- Close
- SHARE
-
- Close
- Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
-
Russell SE, Wrobel AL, Dean OM, Berk M, Dodd S, Ng CH, Malhi GS, Cotton SM, Sarris J, Turner A
- KMID: 2530465
- Clin Psychopharmacol Neurosci.
- 2022 May;20(2):300-310.
- doi: 10.9758/cpn.2022.20.2.300
Objective: There is often a shortfall in recovery following treatment for an episode of bipolar disorder (BD). Exploration of participant’s experience provides vital information to enhance statistical outcomes for novel... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot Study
-
Singh AB, Bousman CA, Ng CH, Byron K, Berk M
- KMID: 2171065
- Clin Psychopharmacol Neurosci.
- 2015 Apr;13(1):53-61.
- doi: 10.9758/cpn.2015.13.1.53
OBJECTIVE: Previous studies suggest child abuse and serotonergic polymorphism influence depression susceptibility and anti-depressant efficacy. Polymorphisms of the norepinephrine transporter (NET) may also be involved. Research in the area is... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
-
Tang ASP, Chan KE, Quek J, Xiao J, Tay P, Teng M, Lee KS, Lin SY, Myint MZ, Tan B, Sharma VK, Tan DJH, Lim WH, Kaewdech A, Huang D, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M, Ng CH
- KMID: 2531373
- Clin Mol Hepatol.
- 2022 Jul;28(3):483-496.
- doi: 10.3350/cmh.2021.0406
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
-
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ
- KMID: 2534351
- Clin Mol Hepatol.
- 2022 Oct;28(4):864-875.
- doi: 10.3350/cmh.2022.0136
Background/Aims: Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
-
Ng CH, Chan KE, Chin YH, Zeng RW, Tsai PC, Lim WH, Tan DJH, Khoo CM, Goh LH, Ling ZJ, Kulkarni A, Mak LYL, Huang DQ, Chan M, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M
- KMID: 2531379
- Clin Mol Hepatol.
- 2022 Jul;28(3):565-574.
- doi: 10.3350/cmh.2022.0096
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted... -
- CITED
-
- Close
- SHARE
-
- Close
